Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 9th:
Celldex Therapeutics, Inc. (CLDX - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.8% over the last 60 days.
Celldex Therapeutics’ shares gained more than 100% over the last one month above the S&P 500’s decline of 2.7%. The company possesses a Momentum Score of A.
GAN Limited (GAN - Free Report) : This provider of enterprise Software-as-a-Service solutions has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.5% over the last 60 days.
GAN’s shares gained 41% over the last one month. The company possesses a Momentum Score of A.
Freeport-McMoRan Inc. (FCX - Free Report) : This company that engages in the mining of mineral properties has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Freeport-McMoRan’s shares gained 11.8% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 9th:
Celldex Therapeutics, Inc. (CLDX - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.8% over the last 60 days.
Celldex Therapeutics’ shares gained more than 100% over the last one month above the S&P 500’s decline of 2.7%. The company possesses a Momentum Score of A.
GAN Limited (GAN - Free Report) : This provider of enterprise Software-as-a-Service solutions has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.5% over the last 60 days.
GAN’s shares gained 41% over the last one month. The company possesses a Momentum Score of A.
Freeport-McMoRan Inc. (FCX - Free Report) : This company that engages in the mining of mineral properties has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Freeport-McMoRan’s shares gained 11.8% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on FCX - FREE
Get the latest research report on CLDX - FREE
Get the latest research report on GAN - FREE